Partner Don Schroeder was quoted in a Corporate Counsel article, “McDonald’s Settles With EEOC for Denying Deaf Job Applicant an Interpreter,” on October 19, 2016. The article discussed a lawsuit by the Equal Employment Opportunity Commission (EEOC) against McDonald’s Corp. after the restaurant canceled an interview when management discovered the applicant was deaf and needed a sign-language interpreter.
Schroeder said this is a reminder that applicants, not just employees, are included in many federal labor laws. He was quoted saying, “The big takeaway from this is that the EEOC – and the Department of Labor and the National Labor Relations Board – have put a hyper-focus upon the inception of employment as a key juncture for determining whether or not an employer dotted the I’s and crossed the T’s under whatever laws were within their jurisdiction.”
Schroeder said this is a reminder that applicants, not just employees, are included in many federal labor laws. He was quoted saying, “The big takeaway from this is that the EEOC – and the Department of Labor and the National Labor Relations Board – have put a hyper-focus upon the inception of employment as a key juncture for determining whether or not an employer dotted the I’s and crossed the T’s under whatever laws were within their jurisdiction.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”